LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 1992
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: A study at a tertiary cancer center

Murthy Sudha S, Sandhya D G, Ahmed Faiq, Goud K Iravathy, Dayal Monal, Suseela K, Rajappa Senthil J

Year : 2011| Volume: 54| Issue : 3 | Page no: 532-538

   This article has been cited by
 
1 Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits
Gyula Pekar,Ionna Kasselaki,Agnes Pekar-Lukacs,Csaba Dekany,Dan Hellberg,Tibor Tot
Histopathology. 2019; 74(2): 300
[Pubmed]  [Google Scholar] [DOI]
2 HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
Yanjun Hou,Hiroaki Nitta,Lai Wei,Peter M. Banks,Bryce Portier,Anil V. Parwani,Zaibo Li
Breast Cancer Research and Treatment. 2017; 166(2): 447
[Pubmed]  [Google Scholar] [DOI]
3 HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
Yanjun Hou,Hiroaki Nitta,Zaibo Li
American Journal of Clinical Pathology. 2017; : aqw211
[Pubmed]  [Google Scholar] [DOI]
4 Utility of cytopathological specimens and an automated image analysis for the evaluation of HER2 status and intratumor heterogeneity in breast carcinoma
Koji Arihiro,Miyo Oda,Katsunari Ogawa,Yoshie Kaneko,Tomomi Shimizu,Yuna Tanaka,Yukari Marubashi,Katsunari Ishida,Chikako Takai,Chie Taoka,Shuji Kimura,Noriyuki Shiroma
Pathology - Research and Practice. 2016; 212(12): 1126
[Pubmed]  [Google Scholar] [DOI]
5 HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases
Xiaoyan Liu,Xiaoling Wang,Bo Wang,Guoping Ren,Wei Ding
Applied Immunohistochemistry & Molecular Morphology. 2016; 24(7): 459
[Pubmed]  [Google Scholar] [DOI]
6 The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas
Hongfei Ji,Qijia Xuan,Abiyasi Nanding,Haiyu Zhang,Qingyuan Zhang,Harriet Wikman
PLOS ONE. 2015; 10(7): e0132824
[Pubmed]  [Google Scholar] [DOI]
7 Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China
Zhihui Zhang,Peng Yuan,Huiqin Guo,Linlin Zhao,Jianming Ying,Mingrong Wang,Huan Zhao,Qinjing Pan,Binghe Xu
Medicine. 2015; 94(24): e981
[Pubmed]  [Google Scholar] [DOI]
8 HER2 assessment by silverin situhybridization: where are we now?
Francesca Sanguedolce,Pantaleo Bufo
Expert Review of Molecular Diagnostics. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
9 Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer
EN-QI QIAO,MINGHUA JI,JIANZHONG WU,JIAN LI,XINYU XU,RONG MA,XIAOHUA ZHANG,YUEJUN HE,QUANBIN ZHA,XUE SONG,LIWEI ZHU,JI-HAI TANG
Molecular and Clinical Oncology. 2013; 1(4): 703
[Pubmed]  [Google Scholar] [DOI]
10 Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers
Fang Zhou,Wensheng Qiu,Lingling Sun,Jinyu Xiang,Xiaoxiao Sun,Aihua Sui,Aiping Ding,Lu Yue
APMIS. 2013; 121(7): 582
[Pubmed]  [Google Scholar] [DOI]
11 HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
Wedad M Hanna,Josef Rüschoff,Michael Bilous,Renata A Coudry,Mitch Dowsett,Robert Y Osamura,Frédérique Penault-Llorca,Marc van de Vijver,Giuseppe Viale
Modern Pathology. 2013;
[Pubmed]  [Google Scholar] [DOI]
12 HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
Han Zhang,Guoping Ren,Xiaoling Wang,Jing Zhao,Hongtian Yao,Yanfeng Bai,Wang Bo
Breast Cancer Research and Treatment. 2012; 134(2): 743
[Pubmed]  [Google Scholar] [DOI]
13 In-situ-Hybridisierung in der klinischen Pathologie
T. Gaiser,J. Rüschoff,R. Moll
Der Pathologe. 2012; 33(S2): 307
[Pubmed]  [Google Scholar] [DOI]

 

Read this article